
Objective:To explore the correlation between CYP2C19 gene polymorphism and clopidogrel resistance in patients with atherosclerotic thrombotic cerebral infarction (ATCI) in Ha'an area.Methods:Three hundred and fifty patients with ATCI admitted to Neurology Department of Hai'an People's Hospital were selected, and classified into extensive metabolizers (EM, n=157), intermediate metabolizers (IM, n=108) and poor metabolizers (PM, n=85) according to CYP2C19 genotype. All patients received clopidogrel treatment for one week upon admission. CYP2C19 genotyping was detected by fluorescence in situ hybridization. The inhibition of adenosine diphosphate (ADP) induced platelet aggregation and maximum amplitude (MA) of clot formation in patients with different CYP2C19 genotypes were measured by thrombelastogram. Then the related factors affecting clopidogrel resistance in ATCI patients were screened.Results:Statistical difference was noted in the smoking, diabetes history, glycosylated hemoglobin (HbAlc) and low-density lipoprotein cholesterol (LDL-C) among different CYP2C19 metabolizers (P<0.05). The inhibition rate of ADP-induced platelet aggregation among different metabolizers was the highest in EM phenotype, followed by IM phenotype, and was the lowest in PM phenotype, with statistical difference (P<0.05). The MA of clot formation among different metabolizers was the largest in PM phenotype, followed by IM phenotype, and was the smallest in EM phenotype, with statistical difference (P<0.05). The incidence rate of clopidogrel resistance in PM phenotype was significantly higher than that of IM and EM phenotype, with statistical difference (P<0.05). Univariate analysis revealed that there were statistically significant differences in smoking, diabetes, and CYP2C19 genotypes among patients with different clopidogrel resistance (P<0.05). Multivariate Logistic regression analysis denoted that smoking, diabetes, CYP2C19 PM and IM phenotype were independent risk factors for clopidogrel resistance in ATCI patients (P<0.05).Conclusion:Clopidogrel resistance is highly prevalent in ATCI patients with CYP2C19 PM and IM phenotype in Hai'an area, and smoking, diabetes mellitus and CYP2C19 PM and IM phenotype are all independent risk factors for the development of clopidogrel resistance in patients.
Objective:To investigate the effect of acupuncture on brain derived neurotrophic factor (BDNF) expression and receptor tyrosine kinase B (TrkB) activity after moderate traumatic brain injury (TBI).Methods:Forty-two adult SD male rats were randomly divided into TBI group (21 rats) and TBI+acupuncture group (21 rats) according to random number table method. The moderate TBI model was established by fluid percussion instrument in both groups. The TBI group was only modeled, and the TBI+acupuncture group was given acupuncture treatment after the TBI model was established. Tissue homogenates and sections were harvested 21 d after moderate TBI. The level of BDNF was examined by ELISA. Immunofluorescence staining was used to detect the expression level of TrkB protein at 6 and 12 h after moderate TBI, Western blot was used to detect the expression levels of TrkB protein at 48, 96, and 168 h after moderate TBI, and the expression of protein kinase B (Akt) and extracellular regulated protein kinase 1/2 (ERK1/2) at 12 and 48 h.Results:The expression level of BDNF protein in two groups of rats reached its peak at 12 h after moderate TBI and gradually decreased at 48 h. The BDNF protein levels in the TBI+acupuncture group were higher than those in the TBI group at 6, 48, 96, 168 h after TBI, with statistical significance (P<0.05), there was no statistically significant difference in BDNF protein levels at 12 h (P>0.05). The levels of p-TrkB protein in the TBI+acupuncture group were higher than those in the TBI group at 6, 12, 48, 96, 168 h, while p-Akt and p-Erk1/2 protein levels were higher than those in the TBI group at 12, 48 h, with statistical significance (P<0.05).Conclusion:Acupuncture therapy can upregulate the expression level of BDNF protein after moderate TBI, and activate TrkB protein by phosphorylation, ultimately activating its downstream signaling pathway.
胆脂瘤常发生于脑桥小脑角区,手术切除是其首选治疗方式。颅神经功能障碍是术后主要并发症,术中神经电生理监测技术的应用降低了术后颅神经功能障碍的发生率,其中对耳蜗神经的保护尤其重要。近些年,多种听力功能监测的方法已在桥小脑角区胆脂瘤切除术中得到了广泛的应用。脑干听觉诱发电位(ABR)联合耳蜗电图(ECochG)在桥小脑角区胆脂瘤切除术中的应用较少,对术后听力丧失的预测价值不明确。本文主要针对ABR联合ECochG在桥小脑角区胆脂瘤切除术中的应用作一介绍。
Objective:To investigate the predictive effect of transcranial color Doppler ultrasound (TCCS) combined with soluble CD40 ligand (sCD40L), fibrinogen (Fib) and platelet activating factor (PAF) on cerebral infarction after transient ischemic attack (TIA).Methods:A total of 128 TIA patients diagnosed and treated by Ultrasound Diagnostic Department of the 82nd Group Military Hospital of PLA from May 2020 to June 2021 were retrospectively selected as the study objects, and were divided into cerebral infarction group (n=36) and non-cerebral infarction group (n=92) according to whether secondary cerebral infarction occurred within 7 d after TIA. TCD blood flow parameters [middle cerebral artery (MCA), peak systolic blood flow velocity (VS), end-diastolic blood flow velocity (Vd), pulsation index (PI), resistance index (RI)], sCD40L, Fib, and PAF were compared between the two groups. ROC curve model was used to analyze the predictive value of color Doppler ultrasound blood flow parameters (VS, Vd, PI, and RI), sCD40L, Fib, PAF and the four combinations in TIA patients with secondary cerebral infarction.Results:VS and Vd in cerebral infarction group were lower than those in non-cerebral infarction group, while PI and RI were higher than those in non-cerebral infarction group (P<0.05). The sCD40L, Fib, and PAF levels in cerebral infarction group were higher than those in non-cerebral infarction group (P<0.05). ROC curve analysis showed that the AUC values of VS, Vd, PI, RI, sCD40L, Fib, PAF and the combined prediction of TIA patients with secondary cerebral infarction were 0.609, 0.772, 0.673, 0.625, 0.677, 0.743, 0.768, 0.944 (P<0.05). Sensitivity was 50.00%, 88.90%, 41.70%, 47.20%, 50.00%, 52.80%, 58.30%, and 86.10%, respectively. The specificity was 93.50%, 62.00%, 97.80%, 100.00%, 92.40%, 90.20%, 93.50%, and 90.20%, respectively. VS, Vd, PI, RI, sCD40L, Fib, PAF were compared with the four combined AUC, and the differences were statistically significant (Z=4.095, 3.628, 4.304, 4.463, 4.178, 3.503, 3.117, all P<0.001).Conclusion:TCD, sCD40L, Fib, and PAF all have certain value in predicting secondary cerebral infarction in TIA patients, but the combined prediction efficiency of the four items is higher.
Intracranial pressure (ICP) is the pressure exerted by the contents of the skull cavity on the wall of the skull cavity. When ICP levels continue to increase in patients with traumatic brain injury (TBI), it may cause a series of nerve damage, and even lead to brain herniation leading to respiratory and circulatory failure and death. The emergence of multi-modal monitoring technology based on ICP monitoring enables clinicians to dynamically and real-time monitor the changes of ICP and related parameters in the treatment of TBI patients. At present, invasive monitoring techniques mainly focus on ventricular type ICP monitoring, with the most accurate results; while many new non-invasive monitoring techniques have also been widely concerned and studied. This article mainly reviews the application of multimodal ICP monitoring technology in TBI treatment, and compares the advantages and disadvantages of various monitoring technologies based on literature, providing a basis for clinical selection of corresponding monitoring methods.